LAWSON HEALTH RES INST has a total of 12 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are TRANSMOLECULAR INC, THE BRIGHAM AND WOMEN'S HOSPITAL INC and NAT JEWISH MED & RES CENTER.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Canada | 4 | |
#3 | Australia | 2 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Remacle Claude | 7 |
#2 | Hill David J | 7 |
#3 | Reusens Brigitte | 7 |
#4 | Xuan Jian Wu | 2 |
#5 | Gelman Neil | 1 |
#6 | Figueredo Rene | 1 |
#7 | Summers Kelly | 1 |
#8 | Goldhawk Donna E | 1 |
#9 | Prato Frank S | 1 |
#10 | Bissell Mina J | 1 |
Publication | Filing date | Title |
---|---|---|
WO2015127527A1 | Co-expression of magnetotactic bacterial genes and genes encoding iron handling proteins in cells | |
WO2011029193A1 | Method of treating cancer by inhibiting trim59 expression or activity | |
WO2009015472A1 | Methods to diagnose type 1 diabetes by measuring cytokine and/or chemokine expression profiles. | |
CA2416440A1 | Compositions and methods for inhibiting islet dysfunction and autoimmune disorders | |
AU6551600A | Compositions and methods for inhibiting islet dysfunction and autoimmune disorders |